Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.

Each year in the UK around 48,500 men are diagnosed with prostate cancer and 11,900 die from the disease. To improve survival, Professor Julia Hippisley-Cox (Nuffield Department of Primary Care and Health Sciences) and Professor Carol Coupland (University of Nottingham) have developed a tool to calculate personalised risk of prostate cancer using the health records of 1.45 million men in the QResearch database. The new risk prediction algorithm aims to diagnose more tumours earlier when they are easier to treat.

The tool is designed to be used for asymptomatic individuals and combines the prostate specific antigen (PSA) blood test result with factors such as age, ethnicity, body mass index, smoking status, social deprivation and family history. Compared to using the PSA test alone, the new algorithm is more accurate at predicting prostate cancer cases (68.2% compared to 43.9% using PSA-only), high-grade aggressive tumours (49.2 % versus 40.3%) and prostate cancer deaths (67% versus 31.5%).

 

The decision in most primary care practices to refer men who are asymptomatic is based on binary PSA thresholds, although this can lead to too many false-negative and false-positive results. Furthermore, a binary threshold does not give any indication for the patient as to their absolute risk of developing prostate cancer and/or clinically significant disease requiring immediate intervention. The results show that the risk equation provides a valid measure of absolute risk and is more efficient at identifying incident cases of prostate cancer, high-grade cancers and prostate cancer deaths than an approach based on a PSA threshold. The intended use is to provide a better evidence base for the GP and patient to improve decision-making regarding the most appropriate action, for example, reassurance, repetition of PSA test, referral for MRI, regular monitoring, referral to a urologist, or use of preventative interventions should any become available. - Professor Julia Hippisley-Cox (Nuffield Department of Primary Care and Health Sciences)

More research is now required to assess the best way to implement the algorithm and evaluate the health economics and the impact on prostate cancer diagnosis and subsequent survival.

 

Read the full publication in the British Journal of General Practice.

Read the feature in the Daily Mail

Similar stories

Identifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers

Dr Defne Saatci and Professor Julia Hippisley-Cox aim to improve early diagnosis of cancers in this age group through earlier recognition of signs and symptoms.